首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   146816篇
  免费   4966篇
  国内免费   850篇
  152632篇
  2023年   200篇
  2022年   585篇
  2021年   1003篇
  2020年   556篇
  2019年   742篇
  2018年   12647篇
  2017年   11267篇
  2016年   8812篇
  2015年   3144篇
  2014年   3137篇
  2013年   3641篇
  2012年   8414篇
  2011年   16588篇
  2010年   14294篇
  2009年   10294篇
  2008年   12881篇
  2007年   14177篇
  2006年   3075篇
  2005年   3050篇
  2004年   3435篇
  2003年   3212篇
  2002年   2657篇
  2001年   1898篇
  2000年   1694篇
  1999年   1241篇
  1998年   535篇
  1997年   489篇
  1996年   410篇
  1995年   393篇
  1994年   311篇
  1993年   326篇
  1992年   658篇
  1991年   552篇
  1990年   481篇
  1989年   486篇
  1988年   421篇
  1987年   403篇
  1986年   318篇
  1985年   329篇
  1984年   277篇
  1983年   241篇
  1982年   191篇
  1981年   162篇
  1979年   220篇
  1978年   197篇
  1977年   179篇
  1976年   170篇
  1974年   196篇
  1972年   401篇
  1971年   397篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
901.
902.
Beta-blockade is of proven value in the therapy of acute myocardial infarction but, unfortunately, may produce cardiac failure by removal of needed sympathetic support. The long duration of action of available blockers (hours) makes reversal of failure a complicated problem and precludes rapid modification of therapy to match changing autonomic conditions. To improve the safety and efficacy of beta-blockade in this setting we have developed the concept of ultra-short beta-blockade and have identified a novel beta-blocker (ASL-8052) which possesses a duration of action less than 15 minutes. This compound is cardioselective and possesses efficacy in an animal model of acute myocardial infarction. It, therefore, appears to be suitable for rapid attainment of controlled levels of beta-blockade via intravenous infusion and rapid recovery from beta-blockade if required by the clinical situation. The compound should, therefore, be useful for safe therapy in critically ill cardiac patients.  相似文献   
903.
904.
905.
A new lignan, (+)-aretigenin has been isolated from the roots of Wikstroemia indica (Nan-Ling-Jao-Hua) and identified as 8(R) 8′(S)-4′-hydroxy-3, 4,3′-trimethoxylignan-olid (9, 9′) on the basis of spectral evidence as well as a direct comparison with its enantiomer, (?)-arctigenin.  相似文献   
906.
Summary Organic components leaked fromSorghum bicolor seedlings (‘root exudates’) were examined by recovering14C labelled compounds from root solutions of seedlings inoculated withAzospirillum brasilense, Azotobacter vinelandii orKlebsiella pneumoniae nif-. Up to 3.5% of the total14C recovered from shoots, roots, and nutrient solutions was found in the root solutions. Inoculation with Azospirillum and Azotobacter increased the amounts of14C and decreased the amounts of carbohydrates in the root solutions. When sucrose was added as a carbon source for the bacteria, the increase of14C in the solutions did not occur. Quantities of14C found in the root solutions were proportional to amounts of mineral nitrogen supplied to the plants. Bacterial growth also was proportional to nitrogen levels. When sorghum plants were grown in soil and labelled with14CO2, about 15% of the total14C recovered within 48 hours exposure was found in soil leachates.  相似文献   
907.
908.
Kidney Stones     
The prevalence of kidney stones has steadily risen during this century; passage of a calculus and a positive family history increase the probability of recurrence. Findings from recent studies on the cause of renal calculi have stressed crystallization and crystal aggregation of stone minerals from supersaturated urine, rather than excessive organic matrix. Absence of normal urine inhibitors of calcium salts is also stressed. Formation of calcium oxalate stones is the major problem. Therapy with decreased calcium and oxalate intake, thiazides, phosphate salts and allopurinol in various combinations has substantially decreased the prevalence of recurrent stones. The rationale for the use of allopurinol is that uric acid salts enhance the tendency for calcium oxalate to crystallize from supersaturated urine. The hypercalciuria seen in 30 percent to 40 percent of patients with oxalate stones is usually caused by intestinal hyperabsorption of calcium. Although patients with uric acid calculi constitute only a small fraction of those in whom stones form, they represent a group in whom good medical therapy, based on sound physiologic principles, has proved extremely successful. Renal tubular syndromes lead to nephrocalcinosis and lithiasis through hypercalciuria, alkaline urine and hypocitraturia, the latter an inhibitor of calcium salt precipitation. Recent advances in surgical techniques are discussed, including the rationale for removing staghorn calculi. The ileal ureter and coagulum pyelolithotomy deserve special emphasis.  相似文献   
909.
Summary The susceptibility of cellulose to enzymatic hydrolysis can be significantly affected through pretreatment by means of gamma-ray radiation. Experiments were carried out to investigate the effects of this radiation on enzymatic hydrolysis and on the two major structural features of cellulose that most influence hydrolysis, namely, specific surface area and crystallinity.D. H. Beardmore is currently with Phillips Petroleum Company, Bartlesville, OK 74004, U.S.A.  相似文献   
910.
The biological properties of the naturally occurring pituitary peptide αh7–38-adrenocorticotropin (ACTH) have been investigated. αh7–38-ACTH is devoid of steroidogenic activity but inhibits competitively ACTH-induced steroidogenesis in vitro as well as in vivo. The long-term actions of ACTH on normal and tumor adrenal cells in culture are also antagonized by αh7–38-ACTH. The apparent Ki for the inhibition of cyclic AMP production by αh7–38-ACTH (301 ± 62 nm) was significantly higher than the apparent Ki for the inhibition of corticosterone synthesis (21.6 ± 6.8 nm). Analysis of the inhibition of ACTH-induced steroidogenesis and cyclic AMP production in normal rat adrenocortical cells indicates that two separate receptors may be involved in mediating these responses.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号